NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Investor Relations
Jaclyn Jaffe
T: 781-652-4500
ir@jmcderm.com
Transfer Agent
VStock Transfer
Allison Niccolls
allison@vstocktransfer.com